/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Adipose-derived Stem Cell Market By Cell type.
Oncorus Appoints Scott Canute to its Board of Directors
Oncorus Appoints Scott Canute to its Board of Directors
CAMBRIDGE, Mass., Dec. 14, 2020 Oncorus, Inc. (Nasdaq: ONCR), a clinical stage biopharmaceutical company developing next-generation viral immunotherapies to transform outcomes for cancer patients, today announced the appointment of Scott Canute, M.B.A. to its Board of Directors. Mr. Canute has nearly 40 years of broad experience in the biopharmaceutical industry, including leading global manufacturing and operations strategy and execution for Genzyme Corporation and Eli Lilly and Company.
“As we execute on our growth plans, including the buildout of our in-house manufacturing capabilities, we are delighted to welcome Scott Canute to our Board of Directors,” said Theodore (Ted) Ashburn, M.D., Ph.D., President and CEO of Oncorus. “We look forward to leveraging Scott’s breadth of experience and insights from leading operations and manufacturing for world-class bi